{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:06:14Z","timestamp":1772046374699,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2259,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/mt.2010.113","type":"journal-article","created":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T14:13:19Z","timestamp":1277215999000},"page":"1519-1526","source":"Crossref","is-referenced-by-count":14,"title":["Introduction of an N-Glycan Sequon Into HEXA Enhances Human \u03b2-Hexosaminidase Cellular Uptake in a Model of Sandhoff Disease"],"prefix":"10.1016","volume":"18","author":[{"given":"Kazuhiko","family":"Matsuoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei-ichi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohji","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2010.113_bib1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2010.113_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2010.113_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2005-837543","article-title":"Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study","volume":"36","author":"Klinge","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1038\/mt.2010.113_bib4","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1073\/pnas.85.6.1883","article-title":"Gene encoding the human beta-hexosaminidase beta chain: extensive homology of intron placement in the alpha- and beta-chain genes","volume":"85","author":"Proia","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.113_bib5","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1016\/S0021-9258(19)83927-3","article-title":"Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease","volume":"261","author":"Korneluk","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.113_bib6","doi-asserted-by":"crossref","first-page":"16276","DOI":"10.1016\/S0021-9258(17)34004-8","article-title":"Expression and specificity of human GM2 activator protein","volume":"269","author":"Wu","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.113_bib7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.bbrc.2004.09.159","article-title":"An alpha-subunit loop structure is required for GM2 activator protein binding by beta-hexosaminidase A","volume":"324","author":"Zarghooni","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2010.113_bib8","series-title":"The Metabolic and Molecular Bases of Inherited Diseases","first-page":"3827","article-title":"The GM2 gangliosidoses","author":"Gravel","year":"2001"},{"key":"10.1038\/mt.2010.113_bib9","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1073\/pnas.75.8.3979","article-title":"AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2","volume":"75","author":"Conzelmann","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.113_bib10","doi-asserted-by":"crossref","first-page":"21705","DOI":"10.1016\/S0021-9258(20)88243-X","article-title":"Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity","volume":"264","author":"Brown","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.113_bib11","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1016\/S0021-9258(19)50196-X","article-title":"Analysis of the glycosylation and phosphorylation of the alpha-subunit of the lysosomal enzyme, beta-hexosaminidase A, by site-directed mutagenesis","volume":"267","author":"Weitz","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.113_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.cb.05.110189.002411","article-title":"The biogenesis of lysosomes","volume":"5","author":"Kornfeld","year":"1989","journal-title":"Annu Rev Cell Biol"},{"key":"10.1038\/mt.2010.113_bib13","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1016\/S0021-9258(18)63825-6","article-title":"Mannose 6-phosphate receptors and lysosomal enzyme targeting","volume":"264","author":"Dahms","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.113_bib14","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1016\/S0021-9258(18)83290-2","article-title":"Analysis of the glycosylation and phosphorylation of the lysosomal enzyme, beta-hexosaminidase B, by site-directed mutagenesis","volume":"264","author":"Sonderfeld-Fresko","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.113_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clineuro.2004.09.007","article-title":"Functional outcome of intrathecal baclofen administration for severe spasticity","volume":"107","author":"Boviatsis","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1038\/mt.2010.113_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jpainsymman.2004.02.018","article-title":"Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients","volume":"28","author":"Rudich","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1038\/mt.2010.113_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.113_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2010.113_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2008.10.021","article-title":"Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease","volume":"215","author":"Dodge","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2010.113_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2010.113_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2006.10.005","article-title":"Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice","volume":"90","author":"Hemsley","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2010.113_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cne.10578","article-title":"Insulin-like growth factor-II\/mannose-6-phosphate receptor:widespread distribution in neurons of the central nervous system including those expressing cholinergic phenotype","volume":"458","author":"Cheryl","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.1038\/mt.2010.113_bib23","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/glycob\/cwp080","article-title":"Production of human beta-hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene","volume":"19","author":"Akeboshi","year":"2009","journal-title":"Glycobiology"},{"key":"10.1038\/mt.2010.113_bib24","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1248\/bpb.29.1564","article-title":"Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice","volume":"29","author":"Itakura","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1038\/mt.2010.113_bib25","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1471-4159.2005.03317.x","article-title":"Metabolic correction in microglia derived from Sandhoff disease model mice","volume":"94","author":"Tsuji","year":"2005","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2010.113_bib26","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/AEM.00463-07","article-title":"Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta","volume":"73","author":"Akeboshi","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1038\/mt.2010.113_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2006.10.010","article-title":"Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies","volume":"378","author":"Tsuji","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1038\/mt.2010.113_bib28","series-title":"Sphingolipid Biochemistry","author":"Hakomori","year":"1983"},{"key":"10.1038\/mt.2010.113_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng1196-348","article-title":"Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis","volume":"14","author":"Sango","year":"1996","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2010.113_bib30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/glycob\/4.6.855","article-title":"Immunohistochemical localization of minor gangliosides in the rat central nervous system","volume":"4","author":"Kotani","year":"1994","journal-title":"Glycobiology"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616311030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616311030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T03:27:54Z","timestamp":1657682874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616311030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1525001616311030"],"URL":"https:\/\/doi.org\/10.1038\/mt.2010.113","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}